• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.08% Nasdaq Up 0.27%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    10.69 Up 0.27(2.59%) 11:36AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:10.42
    Open:10.27
    Bid:10.68 x 700
    Ask:10.69 x 600
    1y Target Est:13.83
    Beta:1.2
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:10.25 - 10.71
    52wk Range:4.13 - 10.98
    Volume:666,788
    Avg Vol (3m):2,412,560
    Market Cap:1.13B
    P/E (ttm):N/A
    EPS (ttm):-1.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKUp 2.59%1.13B
    IMMUDown 3.37%400.47M
    LRUSF 0.00%N/A
    THLDDown 0.32%195.15M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.88
    Quarterly EPS Est (Dec-14) :-0.19
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-2.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback